We are live on
!
Find out more
IE
Israel Englander Millennium Management
AUM
$276B
1-Year Est. Return
44.8%
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
This Fund
S&P 500
This Quarter
Est. Return
-0.14%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$167B
AUM Growth
+$3.7B
(+2.3%)
Cap. Flow
-$692M
Cap. Flow
% of AUM
-0.42%
Top 10 Holdings %
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,245
Increased
2,719
Reduced
2,446
Closed
981
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASZ.U
3151
DELISTED
Austerlitz Acquisition Corporation II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
ASZ.U
| $3.81M | ﹤0.01% |
387,113
-2,145,152
| -85% | -$21.4M |
|
3152
NBT Bancorp
NBTB
$2.68B
| $3.81M | ﹤0.01% |
105,537
+16,822
| +19% | +$591K |
|
|
ZWRKU
3153
DELISTED
Z-Work Acquisition Corp. Units
ZWRKU
| $3.81M | ﹤0.01% |
384,588
-13,151
| -3% | -$130K |
|
3154
Agilon Health
AGL
$1.55B
| $3.81M | ﹤0.01% |
+5,813
| New | +$4.97M |
|
3155
CALL
iShares Silver Trust
SLV
$32.3B
| $3.81M | ﹤0.01% |
185,600
-1,168,400
| -86% | -$26.3M |
|
|
POWRU
3156
DELISTED
Powered Brands Units
POWRU
| $3.8M | ﹤0.01% |
383,711
+2,353
| +0.6% | +$23.4K |
|
|
SKINW
3157
CALL
DELISTED
The Beauty Health Company Warrant expiring 5/4/2026
SKINW
| $3.8M | ﹤0.01% |
262,733
+2,267
| +0.9% | +$24.3K |
|
|
SFR
3158
DELISTED
Appreciate Holdings, Inc. Class A Common Stock
SFR
| $3.79M | ﹤0.01% |
386,961
+225,000
| +139% | +$2.19M |
|
3159
Resideo Technologies
REZI
$2.98B
| $3.79M | ﹤0.01% |
152,903
-40,806
| -21% | -$1.19M |
|
3160
Beazer Homes USA
BZH
$886M
| $3.79M | ﹤0.01% |
219,410
+91,206
| +71% | +$1.63M |
|
3161
Carrier Global
CARR
$48.5B
| $3.78M | ﹤0.01% |
73,060
+1,256
| +2% | +$67.6K |
|
|
ATAQ
3162
DELISTED
Altimar Acquisition Corp III
ATAQ
| $3.78M | ﹤0.01% |
387,877
-87,148
| -18% | -$849K |
|
|
ARGO
3163
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $3.77M | ﹤0.01% |
72,295
+19,716
| +37% | +$1.04M |
|
3164
Aramark
ARMK
$15.3B
| $3.77M | ﹤0.01% |
159,033
-1,325,637
| -89% | -$32.8M |
|
3165
Verra Mobility
VRRM
$667M
| $3.77M | ﹤0.01% |
250,044
+176,105
| +238% | +$2.69M |
|
3166
PUT
iShares MSCI Hong Kong ETF
EWH
$1.26B
| $3.77M | ﹤0.01% |
157,000
-48,000
| -23% | -$1.24M |
|
3167
Novanta
NOVT
$5.38B
| $3.76M | ﹤0.01% |
24,356
+14,391
| +144% | +$2.09M |
|
3168
Toyota
TM
$230B
| $3.76M | ﹤0.01% |
21,155
+19,055
| +907% | +$3.4M |
|
3169
Xos
XOS
$47.8M
| $3.75M | ﹤0.01% |
27,028
-37,815
| -58% | -$9.55M |
|
3170
Lakeland Industries
LAKE
$117M
| $3.75M | ﹤0.01% |
178,730
-47,113
| -21% | -$1.1M |
|
3171
New Jersey Resources
NJR
$5.44B
| $3.75M | ﹤0.01% |
107,694
+100,800
| +1,462% | +$3.81M |
|
|
VBIV
3172
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $3.75M | ﹤0.01% |
40,184
+15,830
| +65% | +$1.5M |
|
|
BHIL
3173
DELISTED
Benson Hill, Inc.
BHIL
| $3.75M | ﹤0.01% |
16,026
+6,551
| +69% | +$2.27M |
|
3174
Amphastar Pharmaceuticals
AMPH
$936M
| $3.74M | ﹤0.01% |
196,938
+180,428
| +1,093% | +$3.53M |
|
3175
Central Garden & Pet Co Class A
CENTA
$2.37B
| $3.74M | ﹤0.01% |
108,830
+88,457
| +434% | +$3.06M |
|
Similar funds
JT
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.